Skip to main content

Featured Article - The need to increase antimicrobial resistance surveillance among forcibly displaced persons (FDPs)

In this case report, Boer et al. describe the treatment of a Dutch patient with tetanus infection and illustrate the role of benzodiazepines as well as other key aspects of treating patients with tetanus. Click here to read more.


Call for Papers

New Content Item

Intoxications and Environmental Insults of Travel is open for submissions.

This series explores the many ways in which non-pathogen based exposures and intoxications can affect travelers, and explore the global epidemiology of such disease risks.

Article Collection: Parasitic Diseases and Immunosuppression

New Content Item

This series entitled Parasitic Diseases and Immunosuppression aims to better illuminate the underpinnings of host-parasite interactions, and to strive towards not just treating but preventing the attributable clinical fallout. 

Aims and scope

Tropical Diseases, Travel Medicine and Vaccines is an open access journal that considers basic, translational and applied research, as well as reviews and commentary, related to the prevention and management of healthcare and diseases in international travelers. Given the changes in demographic trends of travelers globally, as well as the epidemiological transitions which many countries are experiencing, the journal considers non-infectious problems including chronic disease among target populations of interest as well as infectious diseases.

Editor in Chief - Dr Marco Goeijenbier

Dr. Marco Goeijenbier graduated from the University of Amsterdam with a medical degree in 2010, followed by a degree in biomedical science from Erasmus University Rotterdam in 2012. He completed his PhD in virology, focusing on "Haemostasis and Virus Infection," at Erasmus University Rotterdam in 2015.

He currently serves as a specialist in acute internal medicine and critical care at Spaarne Hospital in Haarlem, the Netherlands. His expertise spans various aspects of infectious diseases, particularly in critical care medicine and viral infections.

In addition to his clinical work, Dr. Goeijenbier holds a research position at Erasmus MC in Rotterdam, where he mentors PhD students exploring critical care medicine and viral infections. His research interests focus on severe acute respiratory infection (SARI) pathogenesis, epidemiology, and their interaction with the coagulation system.

Dr. Goeijenbier is the Chair of the Influenza Diabetes Community (IDC). The IDC connects leading diabetes, patient, scientific and professional organisations around the common aim of protecting persons living with diabetes from influenza and other viral respiratory diseases like COVID-19. Starting January 2023, Dr. Goeijenbier also took on the role of Chair of Medical Research and Education at Spaarne Hospital.

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.4
    5-year Journal Impact Factor: 2.5
    Source Normalized Impact per Paper (SNIP): 0.858
    SCImago Journal Rank (SJR): 0.708

    Speed 2023
    Submission to first editorial decision (median days): 8
    Submission to acceptance (median days): 115

    Usage 2023
    Downloads: 312,456
    Altmetric mentions: 262